• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源艰难梭菌毒素特异性记忆 B 细胞库编码中和能力差的抗体。

Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.

机构信息

Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center (OUHSC).

Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, and.

出版信息

JCI Insight. 2020 Aug 20;5(16):138137. doi: 10.1172/jci.insight.138137.

DOI:10.1172/jci.insight.138137
PMID:32663199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7455132/
Abstract

Clostridioides difficile is a leading cause of nosocomial infection responsible for significant morbidity and mortality with limited options for therapy. Secreted C. difficile toxin B (TcdB) is a major contributor to disease pathology, and select TcdB-specific Abs may protect against disease recurrence. However, the high frequency of recurrence suggests that the memory B cell response, essential for new Ab production following C. difficile reexposure, is insufficient. We therefore isolated TcdB-specific memory B cells from individuals with a history of C. difficile infection and performed single-cell deep sequencing of their Ab genes. Herein, we report that TcdB-specific memory B cell-encoded antibodies showed somatic hypermutation but displayed limited isotype class switch. Memory B cell-encoded mAb generated from the gene sequences revealed low to moderate affinity for TcdB and a limited ability to neutralize TcdB. These findings indicate that memory B cells are an important factor in C. difficile disease recurrence.

摘要

艰难梭菌是导致医院感染的主要原因,其发病率和死亡率较高,治疗选择有限。分泌的艰难梭菌毒素 B(TcdB)是疾病发病机制的主要贡献者,选择 TcdB 特异性 Abs 可能有助于预防疾病复发。然而,高复发率表明,记忆 B 细胞反应对于艰难梭菌再次暴露后新 Ab 的产生是不足的。因此,我们从有艰难梭菌感染史的个体中分离出 TcdB 特异性记忆 B 细胞,并对其 Ab 基因进行单细胞深度测序。在此,我们报告 TcdB 特异性记忆 B 细胞编码的抗体显示体细胞超突变,但显示有限的同种型转换。从基因序列生成的记忆 B 细胞编码的 mAb 对 TcdB 的亲和力低至中等,中和 TcdB 的能力有限。这些发现表明,记忆 B 细胞是艰难梭菌病复发的一个重要因素。

相似文献

1
Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.人源艰难梭菌毒素特异性记忆 B 细胞库编码中和能力差的抗体。
JCI Insight. 2020 Aug 20;5(16):138137. doi: 10.1172/jci.insight.138137.
2
Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.记忆B细胞编码针对艰难梭菌菌株VPI 10463和NAP1/BI/027毒素B的中和抗体,但其对VPI 10463毒素B的中和作用更强。
Infect Immun. 2015 Oct 26;84(1):194-204. doi: 10.1128/IAI.00011-15. Print 2016 Jan.
3
Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.艰难梭菌感染诱导的 IgG 应答劣于免疫诱导的 IgG 应答,且与滤泡辅助性 T 细胞和记忆 B 细胞扩增不足有关。
Infect Immun. 2020 Feb 20;88(3). doi: 10.1128/IAI.00829-19.
4
Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.新型艰难梭菌抗毒素(TcdA和TcdB)人源化单克隆抗体在体外对多种临床菌株具有中和作用,并在仓鼠孢子攻击模型中展现出体内效力。
PLoS One. 2016 Jun 23;11(6):e0157970. doi: 10.1371/journal.pone.0157970. eCollection 2016.
5
The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.鼠新生 Fc 受体是将免疫诱导的艰难梭菌特异性 IgG 转运到肠道并预防疾病所必需的,但不会影响疾病易感性。
Infect Immun. 2021 Sep 16;89(10):e0027421. doi: 10.1128/IAI.00274-21. Epub 2021 Jun 7.
6
The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection.已有全抗毒素 B IgG 免疫对复发性艰难梭菌感染结局的影响。
Anaerobe. 2024 Jun;87:102842. doi: 10.1016/j.anaerobe.2024.102842. Epub 2024 Mar 28.
7
Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.艰难梭菌相关腹泻、炎症性肠病和囊性纤维化患者对艰难梭菌毒素 A 和 B 的循环抗体和记忆 B 细胞反应。
PLoS One. 2013 Sep 10;8(9):e74452. doi: 10.1371/journal.pone.0074452. eCollection 2013.
8
Monoclonal antibody-mediated neutralization of Clostridioides difficile toxin does not diminish induction of the protective innate immune response to infection.单克隆抗体介导的艰难梭菌毒素中和作用不会减弱对感染的保护性先天免疫反应的诱导。
Anaerobe. 2024 Aug;88:102859. doi: 10.1016/j.anaerobe.2024.102859. Epub 2024 May 1.
9
Protective efficacy induced by recombinant Clostridium difficile toxin fragments.重组艰难梭菌毒素片段诱导的保护效力。
Infect Immun. 2013 Aug;81(8):2851-60. doi: 10.1128/IAI.01341-12. Epub 2013 May 28.
10
A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.一种具有功能的寡克隆人源化单克隆抗体混合物,能在体外高效中和艰难梭菌毒素A(TcdA)和毒素B(TcdB),在仓鼠感染模型中显示出体内保护作用。
Clin Vaccine Immunol. 2013 Mar;20(3):377-90. doi: 10.1128/CVI.00625-12. Epub 2013 Jan 16.

引用本文的文献

1
toxin A and toxin B inhibit toxin-specific adaptive immune responses through glucosyltransferase-dependent activity.毒素A和毒素B通过依赖葡萄糖基转移酶的活性抑制毒素特异性适应性免疫反应。
bioRxiv. 2025 Aug 2:2025.07.30.667646. doi: 10.1101/2025.07.30.667646.
2
The interplay between host immunity and infection.宿主免疫与感染之间的相互作用。
mBio. 2025 Aug 13;16(8):e0356224. doi: 10.1128/mbio.03562-24. Epub 2025 Jul 1.
3
Memory Cells in Infection and Autoimmunity: Mechanisms, Functions, and Therapeutic Implications.感染与自身免疫中的记忆细胞:机制、功能及治疗意义

本文引用的文献

1
Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.艰难梭菌感染诱导的 IgG 应答劣于免疫诱导的 IgG 应答,且与滤泡辅助性 T 细胞和记忆 B 细胞扩增不足有关。
Infect Immun. 2020 Feb 20;88(3). doi: 10.1128/IAI.00829-19.
2
Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype.产毒为主的艰难梭菌:一种新的临床表型。
Clin Infect Dis. 2020 Jun 10;70(12):2628-2633. doi: 10.1093/cid/ciz727.
3
Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires.
Vaccines (Basel). 2025 Feb 19;13(2):205. doi: 10.3390/vaccines13020205.
4
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant.用合成双TLR配体佐剂辅助的艰难梭菌TcdB疫苗的增强免疫原性
NPJ Vaccines. 2025 Feb 18;10(1):33. doi: 10.1038/s41541-025-01075-3.
5
Gene Expression Dysregulation in Whole Blood of Patients with Infection.感染患者全血中的基因表达失调
Int J Mol Sci. 2024 Nov 25;25(23):12653. doi: 10.3390/ijms252312653.
6
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study.一种含佐剂的艰难梭菌候选疫苗在健康成年人中的安全性和免疫原性:一项随机安慰剂对照1期研究。
J Infect Dis. 2025 Mar 17;231(3):e511-e520. doi: 10.1093/infdis/jiae466.
7
Clostridioides difficile toxin B subverts germinal center and antibody recall responses by stimulating a drug-treatable CXCR4-dependent mechanism.艰难梭菌毒素 B 通过刺激一种可药物治疗的 CXCR4 依赖性机制来颠覆生发中心和抗体回忆反应。
Cell Rep. 2024 May 28;43(5):114245. doi: 10.1016/j.celrep.2024.114245. Epub 2024 May 17.
8
Reviewing the Mouse Model: Insights into Infection Mechanisms.回顾小鼠模型:对感染机制的见解。
Microorganisms. 2024 Jan 27;12(2):273. doi: 10.3390/microorganisms12020273.
9
Mucosal Vaccination Strategies against Infection.针对感染的黏膜疫苗接种策略
Vaccines (Basel). 2023 Apr 23;11(5):887. doi: 10.3390/vaccines11050887.
10
Host Immunity and Immunization Strategies for Clostridioides difficile Infection.艰难梭菌感染的宿主免疫与免疫策略。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0015722. doi: 10.1128/cmr.00157-22. Epub 2023 May 10.
人类抗原特异性记忆 B 细胞 repertoire 分析的见解。
Front Immunol. 2019 Jan 15;9:3064. doi: 10.3389/fimmu.2018.03064. eCollection 2018.
4
fecal toxin level is associated with disease severity and prognosis.粪便毒素水平与疾病严重程度及预后相关。
United European Gastroenterol J. 2018 Jun;6(5):773-780. doi: 10.1177/2050640617750809. Epub 2017 Dec 21.
5
Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro.人免疫球蛋白 M 单克隆抗体可阻断 HIV 在宫颈阴道组织中向免疫细胞的传播,并可阻断体外极化上皮细胞中的传播。
Sci Rep. 2018 Jul 5;8(1):10180. doi: 10.1038/s41598-018-28242-y.
6
Bezlotoxumab (Zinplava) for Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection.贝佐妥单抗(Zinplava)用于感染:首个获批用于预防细菌感染复发的单克隆抗体
P T. 2017 Dec;42(12):735-738.
7
Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice.中和作用不能预测广谱中和单克隆抗体CR6261和CR9114对小鼠致死性H2流感病毒攻击的预防效果。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01603-17. Print 2017 Dec 15.
8
A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections.疫苗作为艰难梭菌感染预防措施的安全性和有效性综述
Vaccines (Basel). 2017 Sep 2;5(3):25. doi: 10.3390/vaccines5030025.
9
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.针对巨细胞病毒糖蛋白B的中和及非中和抗体的保护能力
PLoS Pathog. 2017 Aug 30;13(8):e1006601. doi: 10.1371/journal.ppat.1006601. eCollection 2017 Aug.
10
Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.艰难梭菌感染复发和再次感染的临床、流行病学及微生物学特征
Anaerobe. 2017 Dec;48:147-151. doi: 10.1016/j.anaerobe.2017.08.012. Epub 2017 Aug 19.